Cargando…
Influenza
Influenza continues to baffle humans by its constantly changing nature. The twenty-first century has witnessed considerable advances in the understanding of the influenza viral pathogenesis, its synergy with bacterial infections and diagnostic methods. However, challenges continue: to find a less ex...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091034/ https://www.ncbi.nlm.nih.gov/pubmed/32048225 http://dx.doi.org/10.1007/s12098-020-03214-1 |
_version_ | 1783509980038561792 |
---|---|
author | Dharmapalan, Dhanya |
author_facet | Dharmapalan, Dhanya |
author_sort | Dharmapalan, Dhanya |
collection | PubMed |
description | Influenza continues to baffle humans by its constantly changing nature. The twenty-first century has witnessed considerable advances in the understanding of the influenza viral pathogenesis, its synergy with bacterial infections and diagnostic methods. However, challenges continue: to find a less expensive and more reliable point-of-care test for use in developing countries, to produce more efficacious antiviral drugs, to explore ways to combat emerging antiviral resistance and to develop vaccines that can either be produced in a shorter production time or can overcome the need for annual matching with the circulating influenza strains. Most importantly for India, as a nation that suffered the highest mortality in the influenza pandemic 1918, there is an urgent need to gear up our existing preparedness for the next pandemic which is capable to hit at any moment in time. |
format | Online Article Text |
id | pubmed-7091034 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer India |
record_format | MEDLINE/PubMed |
spelling | pubmed-70910342020-03-24 Influenza Dharmapalan, Dhanya Indian J Pediatr Review Article Influenza continues to baffle humans by its constantly changing nature. The twenty-first century has witnessed considerable advances in the understanding of the influenza viral pathogenesis, its synergy with bacterial infections and diagnostic methods. However, challenges continue: to find a less expensive and more reliable point-of-care test for use in developing countries, to produce more efficacious antiviral drugs, to explore ways to combat emerging antiviral resistance and to develop vaccines that can either be produced in a shorter production time or can overcome the need for annual matching with the circulating influenza strains. Most importantly for India, as a nation that suffered the highest mortality in the influenza pandemic 1918, there is an urgent need to gear up our existing preparedness for the next pandemic which is capable to hit at any moment in time. Springer India 2020-02-11 2020 /pmc/articles/PMC7091034/ /pubmed/32048225 http://dx.doi.org/10.1007/s12098-020-03214-1 Text en © Dr. K C Chaudhuri Foundation 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Review Article Dharmapalan, Dhanya Influenza |
title | Influenza |
title_full | Influenza |
title_fullStr | Influenza |
title_full_unstemmed | Influenza |
title_short | Influenza |
title_sort | influenza |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091034/ https://www.ncbi.nlm.nih.gov/pubmed/32048225 http://dx.doi.org/10.1007/s12098-020-03214-1 |
work_keys_str_mv | AT dharmapalandhanya influenza |